192 related articles for article (PubMed ID: 21439418)
1. Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.
Zhang W; Rhodes SD; Zhao L; He Y; Zhang Y; Shen Y; Yang D; Wu X; Li X; Yang X; Park SJ; Chen S; Turner C; Yang FC
Bone; 2011 Jun; 48(6):1378-87. PubMed ID: 21439418
[TBL] [Abstract][Full Text] [Related]
2. Dystrophic spinal deformities in a neurofibromatosis type 1 murine model.
Rhodes SD; Zhang W; Yang D; Yang H; Chen S; Wu X; Li X; Yang X; Mohammad KS; Guise TA; Bergner AL; Stevenson DA; Yang FC
PLoS One; 2015; 10(3):e0119093. PubMed ID: 25786243
[TBL] [Abstract][Full Text] [Related]
3. Hyperactive transforming growth factor-β1 signaling potentiates skeletal defects in a neurofibromatosis type 1 mouse model.
Rhodes SD; Wu X; He Y; Chen S; Yang H; Staser KW; Wang J; Zhang P; Jiang C; Yokota H; Dong R; Peng X; Yang X; Murthy S; Azhar M; Mohammad KS; Xu M; Guise TA; Yang FC
J Bone Miner Res; 2013 Dec; 28(12):2476-89. PubMed ID: 23703870
[TBL] [Abstract][Full Text] [Related]
4. The haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of neurofibromatosis type 1.
Wu X; Chen S; He Y; Rhodes SD; Mohammad KS; Li X; Yang X; Jiang L; Nalepa G; Snider P; Robling AG; Clapp DW; Conway SJ; Guise TA; Yang FC
PLoS One; 2011; 6(9):e24917. PubMed ID: 21980365
[TBL] [Abstract][Full Text] [Related]
5. A murine model of neurofibromatosis type 1 tibial pseudarthrosis featuring proliferative fibrous tissue and osteoclast-like cells.
El-Hoss J; Sullivan K; Cheng T; Yu NY; Bobyn JD; Peacock L; Mikulec K; Baldock P; Alexander IE; Schindeler A; Little DG
J Bone Miner Res; 2012 Jan; 27(1):68-78. PubMed ID: 21956219
[TBL] [Abstract][Full Text] [Related]
6. Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type I.
Wang W; Nyman JS; Ono K; Stevenson DA; Yang X; Elefteriou F
Hum Mol Genet; 2011 Oct; 20(20):3910-24. PubMed ID: 21757497
[TBL] [Abstract][Full Text] [Related]
7. Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice.
Sharma R; Wu X; Rhodes SD; Chen S; He Y; Yuan J; Li J; Yang X; Li X; Jiang L; Kim ET; Stevenson DA; Viskochil D; Xu M; Yang FC
Hum Mol Genet; 2013 Dec; 22(23):4818-28. PubMed ID: 23863460
[TBL] [Abstract][Full Text] [Related]
8. Bone metabolism markers and bone mineral density in children with neurofibromatosis type-1.
Duman O; Ozdem S; Turkkahraman D; Olgac ND; Gungor F; Haspolat S
Brain Dev; 2008 Oct; 30(9):584-8. PubMed ID: 18362054
[TBL] [Abstract][Full Text] [Related]
9. High bone turnover and accumulation of osteoid in patients with neurofibromatosis 1.
Seitz S; Schnabel C; Busse B; Schmidt HU; Beil FT; Friedrich RE; Schinke T; Mautner VF; Amling M
Osteoporos Int; 2010 Jan; 21(1):119-27. PubMed ID: 19415373
[TBL] [Abstract][Full Text] [Related]
10. Associations of osseous abnormalities in Neurofibromatosis 1.
Alwan S; Armstrong L; Joe H; Birch PH; Szudek J; Friedman JM
Am J Med Genet A; 2007 Jun; 143A(12):1326-33. PubMed ID: 17506102
[TBL] [Abstract][Full Text] [Related]
11. The impact of coexisting genetic mutations on murine optic glioma biology.
Kaul A; Toonen JA; Gianino SM; Gutmann DH
Neuro Oncol; 2015 May; 17(5):670-7. PubMed ID: 25246427
[TBL] [Abstract][Full Text] [Related]
12. Severe Thoracic and Spinal Bone Abnormalities in neurofibromatosis type 1.
Prudhomme L; Delleci C; Trimouille A; Chateil JF; Prodhomme O; Goizet C; Van Gils J
Eur J Med Genet; 2020 Apr; 63(4):103815. PubMed ID: 31783133
[TBL] [Abstract][Full Text] [Related]
13. Is osseous dysplasia a primary feature of neurofibromatosis 1 (NF1)?
Alwan S; Tredwell SJ; Friedman JM
Clin Genet; 2005 May; 67(5):378-90. PubMed ID: 15811002
[TBL] [Abstract][Full Text] [Related]
14. The generalized bone phenotype in children with neurofibromatosis 1: a sibling matched case-control study.
Armstrong L; Jett K; Birch P; Kendler DL; McKay H; Tsang E; Stevenson DA; Hanley DA; Egeli D; Burrows M; Friedman JM
Am J Med Genet A; 2013 Jul; 161A(7):1654-61. PubMed ID: 23713011
[TBL] [Abstract][Full Text] [Related]
15. Mouse models of neurofibromatosis type I: bridging the GAP.
Costa RM; Silva AJ
Trends Mol Med; 2003 Jan; 9(1):19-23. PubMed ID: 12524206
[TBL] [Abstract][Full Text] [Related]
16. Dissecting Clinical Heterogeneity in Neurofibromatosis Type 1.
Monroe CL; Dahiya S; Gutmann DH
Annu Rev Pathol; 2017 Jan; 12():53-74. PubMed ID: 28135565
[TBL] [Abstract][Full Text] [Related]
17. Ras dependent paracrine secretion of osteopontin by Nf1+/- osteoblasts promote osteoclast activation in a neurofibromatosis type I murine model.
Li H; Liu Y; Zhang Q; Jing Y; Chen S; Song Z; Yan J; Li Y; Wu X; Zhang X; Zhang Y; Case J; Yu M; Ingram DA; Yang FC
Pediatr Res; 2009 Jun; 65(6):613-8. PubMed ID: 19247213
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic characterization of transgenic mice harboring Nf1+/- or Nf1-/- osteoclasts in otherwise Nf1+/+ background.
Alanne MH; Siljamäki E; Peltonen S; Väänänen K; Windle JJ; Parada LF; Määttä JA; Peltonen J
J Cell Biochem; 2012 Jun; 113(6):2136-46. PubMed ID: 22307743
[TBL] [Abstract][Full Text] [Related]
19. A Computed Tomography-Based Comparison of Abnormal Vertebrae Pedicles Between Dystrophic and Nondystrophic Scoliosis in Neurofibromatosis Type 1.
Li Y; Luo M; Wang W; Shen M; Xu G; Gao J; Xia L
World Neurosurg; 2017 Oct; 106():898-904. PubMed ID: 28735128
[TBL] [Abstract][Full Text] [Related]
20. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
Gottfried ON; Viskochil DH; Couldwell WT
Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
